Children's Hospital Los Angeles builds on its already strong dose awareness program
LOS ANGELES - GE Healthcare today announced the first US pediatric facility installation of its DoseWatch* technology, a new radiation dose-tracking and reporting solution that can help analyze patient exposure levels over time and impact quality of care, at Children's Hospital Los Angeles.
DoseWatch helps healthcare systems assess and improve their dose management through tracking and archiving dosimetric data and generating integrated statistical analysis by device, operator or protocol. DoseWatch supplements existing dose awareness technologies - capturing standardized dose information on Computed Tomography (CT), Interventional and X-ray systems from a range of equipment vendors. Currently, there are approximately 100 installations of DoseWatch around the globe.
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Recently named one of the nation's top five "Best" children's hospitals by U.S. News & World Report, and an early adopter of GE Healthcare's flagship Discovery CT750 HD low dose CT imaging system, Children's Hospital Los Angeles continues to set the tone for kid-friendly care. As a longtime advocate of the Image Gently Campaign - an initiative by the Alliance for Radiation Safety in Pediatric Imaging to improve dose awareness and promote radiation protection in pediatric imaging - Children's Hospital Los Angeles represents a leader in the field and a perfect collaborating partner for GE Healthcare.
"GE Healthcare has long been committed to working with health care providers, including the nation's leading hospitals, to help them monitor and reduce patient exposure to radiation dose in medical imaging," said Agnes Berzsenyi, general manager for Education and Dose, GE Healthcare. "Pediatric imaging presents an important opportunity for raised awareness and patient care, and we look forward to collaborating with clinical leaders at Children's Hospital Los Angeles as they care for some of the most vulnerable patients."
The growing clinical adoption of DoseWatch in the US and beyond builds upon GE's announcement last year of more than $800 million of investment in low-dose technologies over 15 years, and this year's unveiling of the GE Blueprint for low dose- an unprecedented commitment to help leading US hospitals further reduce average patient exposure to radiation dose in imaging procedures by up to 50 percent via the best technology, protocols and training available.^
